Alpha Teknova (NASDAQ:TKNO) Issues Quarterly Earnings Results

Alpha Teknova (NASDAQ:TKNO) issued its quarterly earnings data on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, Zacks reports. Alpha Teknova had a negative net margin of 55.24% and a negative return on equity of 26.51%. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Trading Down 2.8%

Shares of NASDAQ TKNO traded down $0.14 during mid-day trading on Thursday, reaching $4.81. The company had a trading volume of 354,600 shares, compared to its average volume of 337,389. The stock has a market cap of $257.38 million, a price-to-earnings ratio of -11.45 and a beta of 0.39. Alpha Teknova has a 52 week low of $3.94 and a 52 week high of $10.37. The business’s 50-day moving average is $5.08 and its 200-day moving average is $5.30. The company has a current ratio of 5.87, a quick ratio of 4.70 and a debt-to-equity ratio of 0.17.

Hedge Funds Weigh In On Alpha Teknova

Hedge funds have recently added to or reduced their stakes in the stock. Balyasny Asset Management L.P. increased its holdings in Alpha Teknova by 19.5% during the second quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company’s stock valued at $4,912,000 after buying an additional 163,526 shares during the period. Massar Capital Management LP lifted its holdings in Alpha Teknova by 185.7% during the second quarter. Massar Capital Management LP now owns 200,000 shares of the company’s stock worth $982,000 after buying an additional 130,000 shares during the period. Geode Capital Management LLC boosted its position in Alpha Teknova by 64.4% during the 2nd quarter. Geode Capital Management LLC now owns 298,850 shares of the company’s stock valued at $1,468,000 after acquiring an additional 117,016 shares in the last quarter. Marshall Wace LLP increased its holdings in shares of Alpha Teknova by 83.0% in the 2nd quarter. Marshall Wace LLP now owns 90,032 shares of the company’s stock valued at $442,000 after acquiring an additional 40,825 shares during the period. Finally, Goldman Sachs Group Inc. raised its position in shares of Alpha Teknova by 68.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 90,595 shares of the company’s stock worth $470,000 after acquiring an additional 36,763 shares in the last quarter. 13.81% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on TKNO shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Alpha Teknova in a research report on Wednesday, October 8th. Stephens raised shares of Alpha Teknova to a “strong-buy” rating and set a $8.00 price objective for the company in a research note on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Alpha Teknova has an average rating of “Moderate Buy” and an average price target of $10.00.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.